Sodium Caprylate
CAS 1984-06-1
Sodium Caprylate (CAS 1984-06-1) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| SODIUM CAPRYLATE | 1311123 | SU | MTHSPL |
| Sodium Caprylate | 1311123 | SU | MTHSPL |
| Sodium caprylate | 1311123 | SU | MTHSPL |
| sodium caprylate | 1311123 | SU | MTHSPL |
| sodium caprylate | 1311123 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Sodium Caprylate used for in pharmaceutical contexts?
Sodium Caprylate (CAS 1984-06-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Sodium Caprylate?
No adverse-event association or SIDER side-effect rows are rendered for Sodium Caprylate in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Sodium Caprylate also used in cosmetics?
No same-CAS cosmetics profile is rendered from the ingredients-table cross-reference for Sodium Caprylate.
What clinical phase is Sodium Caprylate in?
No phase 1-4 clinical development badge is rendered for Sodium Caprylate because the matched compound identifier rows do not contain a max-phase value.